nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Alzheimer's Association recommendations for operationalizing the detection of cognitive impairment during the Medicare Annual Wellness Visit in a primary care setting
|
Cordell, Cyndy B. |
|
2013 |
9 |
2 |
p. 141-150 10 p. |
artikel |
2 |
Alzheimer's Association Update
|
|
|
2013 |
9 |
2 |
p. 246-249 4 p. |
artikel |
3 |
2013 Alzheimer's disease facts and figures
|
|
|
2013 |
9 |
2 |
p. 208-245 38 p. |
artikel |
4 |
Amyloid imaging and cognitive decline in nondemented oldest-old: The 90+ Study
|
Kawas, Claudia H. |
|
2013 |
9 |
2 |
p. 199-203 5 p. |
artikel |
5 |
Butyrylcholinesterase genotype and gender influence Alzheimer’s disease phenotype
|
Lane, Roger M. |
|
2013 |
9 |
2 |
p. e17-e73 nvt p. |
artikel |
6 |
Can we prevent Alzheimer's disease? Secondary “prevention” trials in Alzheimer's disease
|
Carrillo, Maria C. |
|
2013 |
9 |
2 |
p. 123-131.e1 1188 p. |
artikel |
7 |
Contents
|
|
|
2013 |
9 |
2 |
p. A1-A2 nvt p. |
artikel |
8 |
Current knowledge and future directions about the disclosure of dementia: A systematic review of the first decade of the 21st century
|
Werner, Perla |
|
2013 |
9 |
2 |
p. e74-e88 nvt p. |
artikel |
9 |
Editorial Board
|
|
|
2013 |
9 |
2 |
p. A5- 1 p. |
artikel |
10 |
Frailty syndrome and the risk of vascular dementia: The Italian Longitudinal Study on Aging
|
Solfrizzi, Vincenzo |
|
2013 |
9 |
2 |
p. 113-122 10 p. |
artikel |
11 |
Frontotemporal degeneration, the next therapeutic frontier: Molecules and animal models for frontotemporal degeneration drug development
|
Boxer, Adam L. |
|
2013 |
9 |
2 |
p. 176-188 13 p. |
artikel |
12 |
Global standardization measurement of cerebral spinal fluid for Alzheimer's disease: An update from the Alzheimer's Association Global Biomarkers Consortium
|
Carrillo, Maria C. |
|
2013 |
9 |
2 |
p. 137-140 4 p. |
artikel |
13 |
Improving dementia care: The role of screening and detection of cognitive impairment
|
Borson, Soo |
|
2013 |
9 |
2 |
p. 151-159 9 p. |
artikel |
14 |
Intracerebral propagation of Alzheimer’s disease: Strengthening evidence of a herpes simplex virus etiology
|
Ball, Melvyn J. |
|
2013 |
9 |
2 |
p. 169-175 7 p. |
artikel |
15 |
Medical and Scientific Advisory Council
|
|
|
2013 |
9 |
2 |
p. A6- 1 p. |
artikel |
16 |
New ELISAs with high specificity for soluble oligomers of amyloid β-protein detect natural Aβ oligomers in human brain but not CSF
|
Yang, Ting |
|
2013 |
9 |
2 |
p. 99-112 14 p. |
artikel |
17 |
Predictors of progression to severe Alzheimer’s disease in an incidence sample
|
Rabins, Peter V. |
|
2013 |
9 |
2 |
p. 204-207 4 p. |
artikel |
18 |
Research and standardization in Alzheimer's trials: Reaching international consensus
|
Carrillo, Maria C. |
|
2013 |
9 |
2 |
p. 160-168 9 p. |
artikel |
19 |
Subscriber information
|
|
|
2013 |
9 |
2 |
p. A7- 1 p. |
artikel |
20 |
The advantages of frontotemporal degeneration drug development (part 2 of frontotemporal degeneration: The next therapeutic frontier)
|
Boxer, Adam L. |
|
2013 |
9 |
2 |
p. 189-198 10 p. |
artikel |
21 |
TOMM40 and APOE: Requirements for replication studies of association with age of disease onset and enrichment of a clinical trial
|
Roses, Allen D. |
|
2013 |
9 |
2 |
p. 132-136 5 p. |
artikel |